Zinc Oxide Pharma
Product description
With over 100 years of experience, Grillo Zinc Powder GmbH is one of the market leaders in developing and producing zinc oxides in different qualities. As a traditional and family-owned company, Grillo offers customer-focused solutions for various uses of zinc oxides. The products are ideally suited for providing end-to-end service for customers focusing on areas of treatment such as skin and wounds.
The pharmaceutically pure zinc oxides from Grillo Zinc Powder GmbH are produced from high-purity SHG zinc by the indirect process (French Process) in compliance with Good Manufacturing Practice (EU-GMP guidelines Part II).
Zinc oxide can be used as active ingredient or excipient in numerous pharmaceutical and cosmetic applications such as skin creams, and pastes, but also in medical applications such as wound dressings and the vulcanization of rubber stoppers.
Registration no. of zinc oxide by Grillo Zinc Powder GmbH: DE_NI_01_Reg_2017_0001
| Tradename | Specific surface area range (m²/g) |
|---|---|
| Zinc Oxide Pharma 4 API | BET 3,0-5,0 |
| Zinc Oxide Pharma 6 API | BET 5,1-7,0 |
| Zinc Oxide Pharma 8 API | BET 7,1-9,0 |
| Zinc Oxide Pharma 4 Excipient | BET 3,0-5,0 |
| Zinc Oxide Pharma 6 Excipient | BET 5,1-7,0 |
| Zinc Oxide Pharma 8 Excipient | BET 7,1-9,0 |
Tradename(s)
Zinkoxid
Country availability
| Austria | Denmark |
| Estonia | Finland |
| Germany | Greece |
| Italy | Latvia |
| Lithuania | Norway |
| Poland | Singapore |
| Spain | Sweden |
| Switzerland | Thailand |
| Vietnam |
Contact person
Nina Allers
Product Manager Healthcare
Further information
2024_BSC_Pharma_Portfolio
pdf (6.2 MB)
Spotlight Zinc Oxide
pdf (444.4 KB)